Recent Findings GLP-1 RAs effectively induce weight loss
Its use is being explored for various health applications, including anti-aging, muscle wasting disorders, and increasing the bodys resting metabolic rate, though its long-term effects and safety are still subjects of ongoing research
The significant gap between the demand for GLP-1s and the ability of users to access them through traditional insurer-mediated distribution channels elevated compounding pharmacies and telehealth companies within the US healthcare landscape as alternative pathways to meet GLP-1 demand
Long-term health impacts are not yet known, but studies[1] have shown a potential link to melanoma, a type of skin cancer
A network meta-analysis published in 2025 confirmed retatrutide demonstrated greater absolute weight reduction compared to tirzepatide across comparable timeframes
hakknda en fazla aratrma yaplan ek besin takviyelerinden biridir